The document by Hervé Seligmann evaluates the effects of the Pfizer COVID 19 vaccine. It raises concerns about potential adverse effects and the adequacy of clinical trial data. The analysis suggests that there may be underreporting of negative outcomes and emphasises the importance of comprehensive post vaccination monitoring to ensure safety and efficacy. The report calls for more transparency and independent studies to validate the vaccine’s safety profile and to better inform public health decisions.